The density of synaptophysin in the m10-/m37-agomir-treated APP/PS1 mice was significantly increased compared to the NC-agomir group (Fig. 7d), suggesting that these two agomirs may have protective effects against synaptic damage in AD. This evidence concerns the gene SYP and Alzheimer disease.